Yes, cirrhosis is the most common cause of portal hypertension. As the liver becomes scarred and stiff, blood flowing through the portal vein meets increasing resistance, and the pressure in that vein rises. Normal portal pressure sits around 5 mmHg. Once it climbs above 6 mmHg, portal hypertension has begun, and at 10 mmHg or higher it becomes clinically significant, meaning complications like fluid buildup and enlarged veins start to develop.
How Cirrhosis Raises Portal Pressure
The liver receives a massive volume of blood through the portal vein, which collects blood from the intestines, spleen, and stomach. In a healthy liver, blood flows through a network of tiny vessels called sinusoids with relatively little resistance. Cirrhosis changes that in two connected ways.
First, the scarring itself physically narrows and distorts the sinusoids, creating a structural barrier to blood flow. Second, the cells lining those sinusoids change their behavior. They become more fibrogenic, meaning they actively tighten and constrict the vessels. Part of this problem involves reduced availability of nitric oxide, a molecule that normally keeps blood vessels relaxed. With less nitric oxide inside the liver, vascular tone increases and resistance climbs further.
These two forces, structural scarring and active vessel constriction, feed off each other. The increased stiffness of the liver itself further impairs the behavior of sinusoidal cells, creating a cycle where portal hypertension worsens as the disease advances. This is why portal pressure tends to rise progressively over time rather than reaching a plateau.
How Portal Hypertension Is Measured
The gold standard test is a procedure called hepatic venous pressure gradient (HVPG) measurement. A catheter is threaded through the neck vein into a hepatic vein, where doctors measure the difference between the wedged (blocked) pressure and the free-flowing pressure. That gap is the HVPG, and it directly reflects portal pressure.
The key thresholds are:
- Above 6 mmHg: portal hypertension is present, though often without symptoms (subclinical).
- Above 10 mmHg: clinically significant portal hypertension. Varices can begin forming, and decompensation becomes a real risk. Patients at or below this threshold have roughly a 90% chance of staying free from varices and major complications.
- Above 12 mmHg: severe portal hypertension. The risk of variceal bleeding rises significantly.
- Above 16 to 20 mmHg: associated with poor outcomes in patients who have already decompensated.
Because HVPG measurement is invasive, doctors increasingly use a noninvasive alternative: transient elastography, which measures liver stiffness with an ultrasound-like device. A liver stiffness value around 22.8 kPa predicts clinically significant portal hypertension with about 79% sensitivity and 88% specificity. It’s not a perfect replacement for direct pressure measurement, but it’s accurate enough to guide initial decisions without a catheter.
Complications That Develop as Pressure Rises
Esophageal Varices
When blood can’t flow easily through the liver, it finds alternative routes. Veins in the esophagus and stomach, which aren’t built to handle high-pressure flow, swell into fragile, balloon-like structures called varices. These typically form once portal pressure exceeds 10 mmHg, and the risk of a dangerous bleed increases once pressure passes 12 mmHg. A ruptured varix can cause life-threatening hemorrhage. Among patients admitted to the hospital with variceal bleeding, about 69% survive the first two weeks, but only about 47% are alive at one year.
Ascites
Ascites, the accumulation of fluid in the abdomen, is the most common major complication of portal hypertension. The mechanism involves a chain reaction. High portal pressure triggers the release of nitric oxide, which dilates blood vessels in the gut and throughout the body. This vasodilation fools the kidneys into sensing low blood volume, so they respond by retaining sodium and water. The extra fluid, combined with low protein levels in the blood that reduce the ability to hold fluid inside vessels, leaks into the abdominal cavity. Both portal hypertension and low albumin need to be present for significant ascites to develop.
Spleen Enlargement and Low Platelets
Back-pressure from the portal vein engorges the spleen, a condition called splenomegaly. An enlarged, overactive spleen traps and destroys blood cells more aggressively than normal, particularly platelets. The result is a drop in platelet count (thrombocytopenia) that correlates inversely with spleen size: the bigger the spleen, the lower the platelet count. The trapped platelets also clear a hormone called thrombopoietin that would otherwise signal the bone marrow to produce more platelets, compounding the problem. This is why a low platelet count on routine blood work is often one of the earliest clues that portal hypertension is developing.
How Portal Pressure Is Managed
The primary medical treatment is a class of drugs called nonselective beta-blockers, which have been the cornerstone of portal hypertension management for over three decades. These medications work by reducing heart rate and constricting blood vessels in the gut, both of which lower the volume of blood flowing into the portal system. Current guidelines recommend them for preventing a first variceal bleed in patients with high-risk varices.
For patients without ascites, starting doses are typically modest and titrated upward with a goal heart rate of 55 to 60 beats per minute. In patients who already have ascites, doses are kept lower and the priority shifts to maintaining adequate blood pressure. An alternative to medication is endoscopic variceal ligation, a procedure where bands are placed around varices during an endoscopy to prevent bleeding.
When medications and endoscopic treatments aren’t enough, a procedure called TIPS (transjugular intrahepatic portosystemic shunt) can directly relieve portal pressure. A radiologist places a small stent between the portal vein and the hepatic vein inside the liver, creating a bypass channel that diverts blood around the scarred tissue. This effectively lowers the pressure gradient and is most commonly used for variceal bleeding that won’t stop with other treatments, or for ascites that doesn’t respond to diuretics. TIPS doesn’t require open surgery since it’s performed through a catheter inserted in the neck vein.
How Liver Function Affects Outlook
Survival with portal hypertension depends heavily on how much liver function remains. Doctors categorize this using scoring systems that account for factors like albumin levels, bilirubin, and the presence of complications. In a study of patients who experienced variceal bleeding, those with the best-preserved liver function had a one-year survival of 78% and a five-year survival of about 52%. Patients with moderate liver damage dropped to 46% at one year and 32% at five years. Those with the most advanced liver failure had only an 11% one-year survival rate.
The practical takeaway is that portal hypertension is not a fixed sentence. At earlier stages, when pressure is subclinical and liver function is still reasonably intact, the risk of complications is low and manageable. As pressure rises and liver function declines, the stakes increase significantly. Reducing portal pressure through medication, managing complications as they arise, and in some cases pursuing liver transplantation are the tools that shape long-term outcomes.